APGE
Apogee Therapeutics, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $134.20
- As of
Share the APGE intelligence card
See APGE live in the terminal
Track APGE's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live APGE terminal, freeActive signals for APGE
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 5.7% - EPS $-1.06 vs $-1.1235 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 8.5% - EPS $-1.11 vs $-1.2127 estimate
Top institutional holders of APGE (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | $23.7M | 0.02% | +167.4% |
| MILLENNIUM MANAGEMENT LLC | $17.1M | 0.01% | , |
| MILLENNIUM MANAGEMENT LLC | $10.6M | 0.00% | -67.3% |
| TWO SIGMA INVESTMENTS, LP | $7.9M | 0.01% | -14.0% |
| MILLENNIUM MANAGEMENT LLC | $7.8M | 0.00% | -34.2% |
| D. E. Shaw & Co., Inc. | $5M | 0.00% | -7.0% |
| TWO SIGMA INVESTMENTS, LP | $4.9M | 0.01% | , |
| D. E. Shaw & Co., Inc. | $4.8M | 0.00% | -37.1% |
| D. E. Shaw & Co., Inc. | $4M | 0.00% | , |
| CITADEL ADVISORS LLC | $1.2M | 0.00% | +110.7% |
| Point72 Asset Management, L.P. | $1.2M | 0.00% | , |
| CITADEL ADVISORS LLC | $298K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, APGE
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more APGE signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to APGEand get the insider, 13F, options, and confluence read in one view.
